Austin Health

Title
Frequency of CNKSR2 mutation in the X-linked epilepsy-aphasia spectrum.
Publication Date
2017-03
Author(s)
Damiano, John A
Burgess, Rosemary
Kivity, Sara
Lerman-Sagie, Tally
Afawi, Zaid
Scheffer, Ingrid E
Berkovic, Samuel F
Hildebrand, Michael S
Subject
CNKSR2
Developmental delay
Epilepsy-aphasia spectrum
Sanger sequencing
Speech delay
Type of document
Journal Article
OrcId
0000-0002-2664-4395
0000-0002-2311-2174
0000-0003-4580-841X
0000-0003-2739-0515
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1111/epi.13666
Abstract
Synaptic proteins are critical to neuronal function in the brain, and their deficiency can lead to seizures and cognitive impairments. CNKSR2 (connector enhancer of KSR2) is a synaptic protein involved in Ras signaling-mediated neuronal proliferation, migration and differentiation. Mutations in the X-linked gene CNKSR2 have been described in patients with seizures and neurodevelopmental deficits, especially those affecting language. In this study, we sequenced 112 patients with phenotypes within the epilepsy-aphasia spectrum (EAS) to determine the frequency of CNKSR2 mutation within this complex set of disorders. We detected a novel nonsense mutation (c.2314 C>T; p.Arg712*) in one Ashkenazi Jewish family, the male proband of which had a severe epileptic encephalopathy with continuous spike-waves in sleep (ECSWS). His affected brother also had ECSWS with better outcome, whereas the sister had childhood epilepsy with centrotemporal spikes. This mutation segregated in the three affected siblings in an X-linked manner, inherited from their mother who had febrile seizures. Although the frequency of point mutation is low, CNKSR2 sequencing should be considered in families with suspected X-linked EAS because of the specific genetic counseling implications.
Link
Citation
Epilepsia 2017; 58(3): e40-e43
Jornal Title
Epilepsia

Files:

NameSizeformatDescriptionLink